Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
M Stoll, … , R Metzger, T Unger
M Stoll, … , R Metzger, T Unger
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):651-657. https://doi.org/10.1172/JCI117710.
View: Text | PDF
Research Article Article has an altmetric score of 3

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  • Text
  • PDF
Abstract

Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.

Authors

M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 5 2 4 4 2 5 3 5 3 12 4 9 15 16 25 16 18 16 16 29 28 30 39 54 50 69 61 54 45 11 651
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2010 (25)

Title and authors Publication Year
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
C Doi, N Egashira, A Kawabata, DK Maurya, N Ohta, D Uppalapati, R Ayuzawa, L Pickel, Y Isayama, D Troyer, S Takekoshi, M Tamura
BMC Cancer 2010
Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases
EI Ager, WW Chong, SW Wen, C Christophi
Cancer Cell International 2010
Angiogenesis and Melanoma
D Ribatti, T Annese, V Longo
Cancers 2010
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
L Shi, C Mao, Z Xu, L Zhang
Drug Discovery Today 2010
Telmisartan regresses left ventricular hypertrophy in caveolin-1 deficient mice
MH Krieger, AD Lorenzo, C Teutsch, K Kauser, WC Sessa
Laboratory Investigation 2010
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
NC Li, A Lee, RA Whitmer, M Kivipelto, E Lawler, LE Kazis, B Wolozin
BMJ (Clinical research ed.) 2010
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli
Burger's Medicinal Chemistry and Drug Discovery 2010
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis
M Sata, D Fukuda
The Journal of Medical Investigation 2010
Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium
T Hasin, O Elhanani, Z Abassi, T Hai, A Aronheim
Basic Research in Cardiology 2010
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T Dolley-Hitze, F Jouan, B Martin, S Mottier, J Edeline, O Moranne, PL Pogamp, MA Belaud-Rotureau, JJ Patard, N Rioux-Leclercq, C Vigneau
British Journal of Cancer 2010
Losartan Inhibits Vascular Smooth Muscle Cell Proliferation through Activation of AMP-Activated Protein Kinase
JE Kim, HC Choi
The Korean Journal of Physiology and Pharmacology 2010
The angiotensin AT2 receptor in left ventricular hypertrophy
UM Steckelings, RE Widdop, L Paulis, T Unger
Journal of Hypertension 2010
Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells
MO Guimond, C Roberge, N Gallo-Payet
Molecular and Cellular Neuroscience 2010
Liver regeneration and tumour stimulation: implications of the renin-angiotensin system
SL Koh, EI Ager, C Christophi
Liver International 2010
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases
JH Neo, EI Ager, PW Angus, J Zhu, CB Herath, C Christophi
BMC Cancer 2010
Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
L Pickel, T Matsuzuka, C Doi, R Ayuzawa, DK Maurya, SX Xie, C Berkland, M Tamura
Cancer biology & therapy 2010
Ethanol-induced downregulation of the angiotensin AT2 receptor in murine fibroblasts is mediated by PARP-1
M Menk, C Haefen, H Funke-Kaiser, M Sifringer, JH Schefe, S Kirsch, K Seidel, J Reinemund, UM Steckelings, T Unger, CD Spies
Alcohol 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Comprehensive Toxicology
JM Sands, JW Verlander
Comprehensive Toxicology 2010
xPharm: The Comprehensive Pharmacology Reference
A Vinh
xPharm: The Comprehensive Pharmacology Reference 2010
Burden of illness among patients at high risk versus low risk for major cardiovascular events
C Harley, SD Sander, V Zarotsky, F Cao, H Shah
Journal of Medical Economics 2010
Developmental changes in AT1 and AT2 receptor-protein expression in rats
L Yu, M Zheng, W Wang, GJ Rozanski, IH Zucker, L Gao
Journal of Renin-Angiotensin-Aldosterone System 2010
Skeletal muscle-endothelial cell cross talk through angiotensin II
LM Bellamy, AP Johnston, MD Lisio, G Parise
American journal of physiology. Cell physiology 2010
The Promyelocytic Leukemia Zinc Finger (PLZF) Protein Exerts Neuroprotective Effects in Neuronal Cells and is Dysregulated in Experimental Stroke: Neuroprotective Effects of PLZF
K Seidel, S Kirsch, K Lucht, D Zaade, J Reinemund, J Schmitz, S Klare, Y Li, JH Schefe, K Schmerbach, P Goldin-Lang, FS Zollmann, C Thöne-Reineke, T Unger, H Funke-Kaiser
Brain Pathology 2010

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
94 readers on Mendeley
See more details